PlusPedia wird derzeit technisch modernisiert. Aktuell laufen Wartungsarbeiten.

Neue User bitte dringend diese Hinweise lesen:

Anmeldung - E-Mail-Adresse Neue Benutzer benötigen ab sofort eine gültige e-mail-adresse. Wenn keine e-mail ankommt, meldet Euch bitte unter NewU25@PlusPedia.de.

PlusPedia wird derzeit technisch modernisiert. Wie alles, was bei laufendem Betrieb bearbeitet wird, kann es auch hier zu zeitweisen Ausfällen bestimmter Funktionen kommen. Es sind aber alle Artikel zugänglich, Sie können PlusPedia genauso nutzen wie immer.

Hinweis zur Passwortsicherheit:
Bitte nutzen Sie Ihr PlusPedia-Passwort nur bei PlusPedia.
Wenn Sie Ihr PlusPedia-Passwort andernorts nutzen, ändern Sie es bitte DORT bis unsere Modernisierung abgeschlossen ist.
Überall wo es sensibel, sollte man generell immer unterschiedliche Passworte verwenden! Das gilt hier und im gesamten Internet.
Aus Gründen der Sicherheit (PlusPedia hatte bis 24.07.2025 kein SSL | https://)


Bei PlusPedia sind Sie sicher: – Wir verarbeiten keine personenbezogenen Daten, erlauben umfassend anonyme Mitarbeit und erfüllen die Datenschutz-Grundverordnung (DSGVO) vollumfänglich. Es haftet der Vorsitzende des Trägervereins.

PlusPedia blüht wieder auf als freundliches deutsches Lexikon.
Wir haben auf die neue Version 1.43.3 aktualisiert.
Wir haben SSL aktiviert.
Hier geht es zu den aktuellen Aktuelle Ereignissen


Adenohypophyse: Unterschied zwischen den Versionen

Aus PlusPedia
Zur Navigation springen Zur Suche springen
← Zum vorherigen Versionsunterschied
VisuellWikitext
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
KKeine Bearbeitungszusammenfassung
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
KKeine Bearbeitungszusammenfassung
 
Zeile 1: Zeile 1:
[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
{| class="wikitable" |
{| class="wikitable" |
| bgcolor="#dfdfdf" | '''Siehe auch'''
| align="left" width="800" |
|-
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |<ref name="PMID9922367">Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79(1):1-71 (1999) PMID 9922367 </ref><ref name="PMID12202459">Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23(4):431-42 (2002) PMID 12202459 </ref><ref name="PMID11041446">Intercellular communication in the anterior pituitary. Endocr Rev 21(5):488-513 (2000) PMID 11041446 </ref><ref name="PMID10204115">The molecular pathogenesis of corticotroph tumors. Endocr Rev 20(2):136-55 (1999) PMID 10204115 </ref><ref name="PMID9861546">The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19(6):798-827 (1998) PMID 9861546 </ref><ref name="PMID4356692">Adenohypophysis: ultrastructural cytochemistry. A review. J Histochem Cytochem 21(10):855-94 (1973) PMID 4356692 </ref><ref name="PMID19759870">Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Acta Histochem Cytochem 42(4):95-104 (2009) PMID 19759870 </ref><ref name="PMID10495875">The structure and function of folliculo-stellate cells in the anterior pituitary gland. Arch Histol Cytol 62(3):205-18 (1999) PMID 10495875 </ref><ref name="PMID7961905">Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269(47):29335-8 (1994) PMID 7961905 </ref>
| align="left" width="800" |<ref name="PMID9922367">Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79(1):1-71 (1999) PMID 9922367 </ref><ref name="PMID12202459">Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23(4):431-42 (2002) PMID 12202459 </ref><ref name="PMID11041446">Intercellular communication in the anterior pituitary. Endocr Rev 21(5):488-513 (2000) PMID 11041446 </ref><ref name="PMID10204115">The molecular pathogenesis of corticotroph tumors. Endocr Rev 20(2):136-55 (1999) PMID 10204115 </ref><ref name="PMID9861546">The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19(6):798-827 (1998) PMID 9861546 </ref><ref name="PMID4356692">Adenohypophysis: ultrastructural cytochemistry. A review. J Histochem Cytochem 21(10):855-94 (1973) PMID 4356692 </ref><ref name="PMID19759870">Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Acta Histochem Cytochem 42(4):95-104 (2009) PMID 19759870 </ref><ref name="PMID10495875">The structure and function of folliculo-stellate cells in the anterior pituitary gland. Arch Histol Cytol 62(3):205-18 (1999) PMID 10495875 </ref><ref name="PMID7961905">Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269(47):29335-8 (1994) PMID 7961905 </ref><ref name="PMID9735086">Management of pituitary tumors. Ann Intern Med 129(6):472-83 (1998) PMID 9735086 </ref><ref name="PMID8323093">Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119(3):236-40 (1993) PMID 8323093 </ref><ref name="PMID18809592">The diagnosis and management of parasellar tumours of the pituitary. Endocr Relat Cancer 15(4):885-903 (2008) PMID 18809592 </ref><ref name="PMID18780796">Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 15(4):905-15 (2008) PMID 18780796 </ref><ref name="PMID11733226">Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 8(4):287-305 (2001) PMID 11733226 </ref><ref name="PMID15601904">Folliculo-stellate (FS) cells of the anterior pituitary mediate interactions between the endocrine and immune systems. Endocrinology 146(1):33-4 (2005) PMID 15601904 </ref><ref name="PMID17893250">The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371-82 (2007) PMID 17893250 </ref><ref name="PMID17413190">Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Eur J Endocrinol 156 Suppl 1():S57-63 (2007) PMID 17413190 </ref><ref name="PMID17413188">Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S45-51 (2007) PMID 17413188 </ref><ref name="PMID17413187">Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S37-43 (2007) PMID 17413187 </ref><ref name="PMID17413185">Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. Eur J Endocrinol 156 Suppl 1():S29-35 (2007) PMID 17413185 </ref><ref name="PMID17413182">The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S1 (2007) PMID 17413182 </ref><ref name="PMID17287412">Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156(2):225-31 (2007) PMID 17287412 </ref><ref name="PMID17287410">Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203-16 (2007) PMID 17287410 </ref><ref name="PMID17287403">What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 156(2):143-53 (2007) PMID 17287403 </ref><ref name="PMID16990651">Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155(4):523-34 (2006) PMID 16990651 </ref><ref name="PMID16322376">Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol 153(6):723-35 (2005) PMID 16322376 </ref><ref name="PMID14585081">Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149(5):363-76 (2003) PMID 14585081 </ref><ref name="PMID10037250">Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur J Endocrinol 140(1):43-7 (1999) PMID 10037250 </ref><ref name="PMID17613551">Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet 16 Spec No 1():R73-9 (2007) PMID 17613551 </ref><ref name="PMID12636229">Therapy for lymphocytic adenohypophysitis. Intern Med 42(2):137-8 (2003) PMID 12636229 </ref><ref name="PMID11579939">Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia. Intern Med 40(9):845-6 (2001) PMID 11579939 </ref><ref name="PMID9187559">Lymphocytic adenohypophysitis and neurohypophysitis. Intern Med 36(4):238-9 (1997) PMID 9187559 </ref><ref name="PMID19056842">The cabergoline-resistant prolactinoma patient: new challenges. J Clin Endocrinol Metab 93(12):4643-5 (2008) PMID 19056842 </ref><ref name="PMID18682516">Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93(10):3717-26 (2008) PMID 18682516 </ref><ref name="PMID18029460">Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 93(2):393-9 (2008) PMID 18029460 </ref><ref name="PMID17682084">Long-term management of prolactinomas. J Clin Endocrinol Metab 92(8):2861-5 (2007) PMID 17682084 </ref><ref name="PMID17554056">Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 92(6):2038-40 (2007) PMID 17554056 </ref><ref name="PMID15741248">Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90(5):3089-99 (2005) PMID 15741248 </ref><ref name="PMID11600505">Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab 86(10):4567-75 (2001) PMID 11600505 </ref><ref name="PMID10999785">Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab 85(9):3053-7 (2000) PMID 10999785 </ref><ref name="PMID10599692">Pediatric pituitary adenomas. J Clin Endocrinol Metab 84(12):4385-9 (1999) PMID 10599692 </ref><ref name="PMID10599681">Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84(12):4317-23 (1999) PMID 10599681 </ref><ref name="PMID10566620">Clinical review 110: Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84(11):3859-66 (1999) PMID 10566620 </ref><ref name="PMID14660734">Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112(11):1603-18 (2003) PMID 14660734 </ref><ref name="PMID17142570">My approach to pathology of the pituitary gland. J Clin Pathol 59(12):1245-53 (2006) PMID 17142570 </ref><ref name="PMID12890801">Best Practice No 172: pituitary gland pathology. J Clin Pathol 56(8):561-8 (2003) PMID 12890801 </ref><ref name="PMID9659280">Current perspectives on the pathogenesis of clinically non-functioning pituitary tumours. J Endocrinol 157(2):177-86 (1998) PMID 9659280 </ref><ref name="PMID10329742">Neurology of the pituitary gland. J Neurol Neurosurg Psychiatry 66(6):703-21 (1999) PMID 10329742 </ref><ref name="PMID17895459">Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298(12):1429-38 (2007) PMID 17895459 </ref><ref name="PMID8761496">The evaluation and management of subclinical pituitary disease. Postgrad Med J 72(847):258-62 (1996) PMID 8761496 </ref><ref name="PMID3748928">Pituitary apoplexy and haemorrhage into adenomas. Postgrad Med J 62(729):623-6 (1986) PMID 3748928 </ref><ref name="PMID1013000">The empty sella syndrome. Postgrad Med J 52(613):703-5 (1976) PMID 1013000 </ref><ref name="PMID7747512">Advances in diagnosing and managing pituitary adenomas. West J Med 162(4):371-3 (1995) PMID 7747512 </ref><ref name="PMID7747500">Pituitary tumors. Current concepts in diagnosis and management. West J Med 162(4):340-52 (1995) PMID 7747500 </ref><ref name="PMID6659493">Prolactinoma. West J Med 139(5):703-5 (1983) PMID 6659493 </ref><ref name="PMID6998138">Pituitary tumors--current concepts of diagnosis and therapy. West J Med 133(3):189-96 (1980) PMID 6998138 </ref>
|-
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''

Aktuelle Version vom 20. Februar 2010, 13:09 Uhr

Entstehender Artikel
Siehe auch
Freie Übersichtsartikel [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das ACTH MSH POMC CRH Prolaktin Wachstumshormon TSH THR FSH LH LHRH Dopamin
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten


Bibliographie

  1. ↑ Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79(1):1-71 (1999) PMID 9922367
  2. ↑ Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23(4):431-42 (2002) PMID 12202459
  3. ↑ Intercellular communication in the anterior pituitary. Endocr Rev 21(5):488-513 (2000) PMID 11041446
  4. ↑ The molecular pathogenesis of corticotroph tumors. Endocr Rev 20(2):136-55 (1999) PMID 10204115
  5. ↑ The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19(6):798-827 (1998) PMID 9861546
  6. ↑ Adenohypophysis: ultrastructural cytochemistry. A review. J Histochem Cytochem 21(10):855-94 (1973) PMID 4356692
  7. ↑ Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Acta Histochem Cytochem 42(4):95-104 (2009) PMID 19759870
  8. ↑ The structure and function of folliculo-stellate cells in the anterior pituitary gland. Arch Histol Cytol 62(3):205-18 (1999) PMID 10495875
  9. ↑ Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269(47):29335-8 (1994) PMID 7961905
  10. ↑ Management of pituitary tumors. Ann Intern Med 129(6):472-83 (1998) PMID 9735086
  11. ↑ Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119(3):236-40 (1993) PMID 8323093
  12. ↑ The diagnosis and management of parasellar tumours of the pituitary. Endocr Relat Cancer 15(4):885-903 (2008) PMID 18809592
  13. ↑ Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 15(4):905-15 (2008) PMID 18780796
  14. ↑ Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 8(4):287-305 (2001) PMID 11733226
  15. ↑ Folliculo-stellate (FS) cells of the anterior pituitary mediate interactions between the endocrine and immune systems. Endocrinology 146(1):33-4 (2005) PMID 15601904
  16. ↑ The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371-82 (2007) PMID 17893250
  17. ↑ Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Eur J Endocrinol 156 Suppl 1():S57-63 (2007) PMID 17413190
  18. ↑ Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S45-51 (2007) PMID 17413188
  19. ↑ Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S37-43 (2007) PMID 17413187
  20. ↑ Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. Eur J Endocrinol 156 Suppl 1():S29-35 (2007) PMID 17413185
  21. ↑ The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas. Eur J Endocrinol 156 Suppl 1():S1 (2007) PMID 17413182
  22. ↑ Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156(2):225-31 (2007) PMID 17287412
  23. ↑ Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203-16 (2007) PMID 17287410
  24. ↑ What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 156(2):143-53 (2007) PMID 17287403
  25. ↑ Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155(4):523-34 (2006) PMID 16990651
  26. ↑ Diagnosis and management of pituitary tumours in the elderly: a review based on personal experience and evidence of literature. Eur J Endocrinol 153(6):723-35 (2005) PMID 16322376
  27. ↑ Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149(5):363-76 (2003) PMID 14585081
  28. ↑ Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur J Endocrinol 140(1):43-7 (1999) PMID 10037250
  29. ↑ Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet 16 Spec No 1():R73-9 (2007) PMID 17613551
  30. ↑ Therapy for lymphocytic adenohypophysitis. Intern Med 42(2):137-8 (2003) PMID 12636229
  31. ↑ Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia. Intern Med 40(9):845-6 (2001) PMID 11579939
  32. ↑ Lymphocytic adenohypophysitis and neurohypophysitis. Intern Med 36(4):238-9 (1997) PMID 9187559
  33. ↑ The cabergoline-resistant prolactinoma patient: new challenges. J Clin Endocrinol Metab 93(12):4643-5 (2008) PMID 19056842
  34. ↑ Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93(10):3717-26 (2008) PMID 18682516
  35. ↑ Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab 93(2):393-9 (2008) PMID 18029460
  36. ↑ Long-term management of prolactinomas. J Clin Endocrinol Metab 92(8):2861-5 (2007) PMID 17682084
  37. ↑ Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J Clin Endocrinol Metab 92(6):2038-40 (2007) PMID 17554056
  38. ↑ Clinical review: Diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90(5):3089-99 (2005) PMID 15741248
  39. ↑ Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab 86(10):4567-75 (2001) PMID 11600505
  40. ↑ Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab 85(9):3053-7 (2000) PMID 10999785
  41. ↑ Pediatric pituitary adenomas. J Clin Endocrinol Metab 84(12):4385-9 (1999) PMID 10599692
  42. ↑ Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84(12):4317-23 (1999) PMID 10599681
  43. ↑ Clinical review 110: Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84(11):3859-66 (1999) PMID 10566620
  44. ↑ Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112(11):1603-18 (2003) PMID 14660734
  45. ↑ My approach to pathology of the pituitary gland. J Clin Pathol 59(12):1245-53 (2006) PMID 17142570
  46. ↑ Best Practice No 172: pituitary gland pathology. J Clin Pathol 56(8):561-8 (2003) PMID 12890801
  47. ↑ Current perspectives on the pathogenesis of clinically non-functioning pituitary tumours. J Endocrinol 157(2):177-86 (1998) PMID 9659280
  48. ↑ Neurology of the pituitary gland. J Neurol Neurosurg Psychiatry 66(6):703-21 (1999) PMID 10329742
  49. ↑ Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review. JAMA 298(12):1429-38 (2007) PMID 17895459
  50. ↑ The evaluation and management of subclinical pituitary disease. Postgrad Med J 72(847):258-62 (1996) PMID 8761496
  51. ↑ Pituitary apoplexy and haemorrhage into adenomas. Postgrad Med J 62(729):623-6 (1986) PMID 3748928
  52. ↑ The empty sella syndrome. Postgrad Med J 52(613):703-5 (1976) PMID 1013000
  53. ↑ Advances in diagnosing and managing pituitary adenomas. West J Med 162(4):371-3 (1995) PMID 7747512
  54. ↑ Pituitary tumors. Current concepts in diagnosis and management. West J Med 162(4):340-52 (1995) PMID 7747500
  55. ↑ Prolactinoma. West J Med 139(5):703-5 (1983) PMID 6659493
  56. ↑ Pituitary tumors--current concepts of diagnosis and therapy. West J Med 133(3):189-96 (1980) PMID 6998138

Andere Lexika

Abgerufen von „https://h.suprapedia.de/w/index.php?title=Adenohypophyse&oldid=28218“